CLINICAL_TRIALS
trial_result
· 2013-08-13
Clinical Trial Update: A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis C [Phase 1]
Summary
Phase 1 study evaluating GS-9620 in treatment-naive subjects with chronic hepatitis C has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED